Abigail Capobianco

Abigail Capobianco is currently the Director of US Vaccines Communications at GSK, a position held since July 2023. Prior experience includes serving as a Press Officer at the FDA from March 2015 to August 2023, where responsibilities involved acting as the lead spokesperson on critical regulatory issues and coordinating communication strategies with various governmental bodies. Abigail's earlier roles include Writer/Editor at the FDA focusing on tobacco-related topics, Health Communications Specialist managing social media communications, and communications consultancy positions at Health Care Without Harm and NCDFREE. Abigail holds a Master of Arts in Health Communication from Emerson College and a Bachelor of Arts in Journalism from Northeastern University.